Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon

Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon

US Patent 12049639 · Granted Jul 30, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon2023
Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon2023
Methods and compositions for protein delivery2020
Methods and compositions for protein delivery2020
Delivery of packaged RNA to mammalian cells2020
Delivery of packaged RNA to mammalian cells2020
Methods and compositions for protein delivery2018
Methods and compositions for protein delivery2018
Delivery of packaged RNA to mammalian cells2016
Delivery of packaged RNA to mammalian cells2016
Methods for production of proteins2016
Methods and compositions for protein delivery2016